NL-OMON23446已完成不适用
Efficacy and safety of adalimumab (humira) in patients with peripheral spondyloarthritis without ankylosing spondylitis or psoriatic artritis.
dr Baeten0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Leeftijd 18-70;
- •2. 3 maanden diagnose perifere spondyloartritis en niet voldoen aan classificatie spondylitis ankylosans;
排除标准
- •1. In 2 maanden voor start behandeling met anti-TNF of andere studie-medicatie;
- •2. In 4 weken voor start een intra articulaire inject met corticosteroiden;
研究者
相似试验
已完成
不适用
Efficacy and Safety of Adalimumab in Patients With Rheumatoid Arthritis in Routine Clinical PracticeRheumatoid ArthritisNCT01077258AbbVie (prior sponsor, Abbott)4,208
已完成
不适用
Effectiveness and Safety of Adalimumab in Rheumatoid Arthritis Patients in Routine Clinical PracticeRheumatoid ArthritisNCT01078090AbbVie (prior sponsor, Abbott)5,745
已完成
不适用
Safety and Effectiveness of Adalimumab in Patients Diagnosed With Rheumatoid ArthritisRheumatoid ArthritisNCT01078571Abbott705
进行中（未招募）
不适用
EFFICACY AND SAFETY OF ADALIMUMAB (HUMIRA®) IN PATIENTS WITH PERIPHERAL SPONDYLOARTHRITIS WITHOUT ANKYLOSING SPONDYLITIS OR PSORIATIC ARTHRITISPERIPHERAL SPONDYLOARTHRITIS WITHOUT ANKYLOSING SPONDYLITIS OR PSORIATIC ARTHRITISMedDRA version: 9.1Level: LLTClassification code 10051265Term: SpondyloarthropathyEUCTR2008-006885-27-NLClinical Immunology and Rheumatology
已完成
不适用
Evaluation of the Usefulness of Adalimumab in Patients with Psoriatic arthritispsoriatic arthritisJPRN-UMIN000016543agoya City University Graduate School of Medical Sciences, Department of Geriatric and Environmental Dermatology50